<DOC>
	<DOCNO>NCT00488241</DOCNO>
	<brief_summary>To show efficacy Zarzenda treatment hand eczema</brief_summary>
	<brief_title>Multicenter Clinical Study Examine Efficacy Safety Zarzenda Patients With Hand Eczema</brief_title>
	<detailed_description>The objective study demonstrate efficacy safety Zarzenda ( medical device ) management hand eczema .</detailed_description>
	<mesh_term>Eczema</mesh_term>
	<criteria>Mild moderate hand eczema least 3 month At least 4 week pass since use systemic treatment eczema At least 4 week pass since vaccination At least 1 week pass since last topic treatment hand corticosteroid Agree use adequate contraceptive method childbearing potential Willingness avoid excessive exposure sunlight avoid skin irritant Pregnancy , breast feeding Severe excoriation hand Need systemic treatment atopic dermatitis Known sensitivity Zarzenda and/or extract nut butyrospermum parkii ( shea ) Known immune deficiency Concomitant infection hand</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>Eczema</keyword>
	<keyword>Medical device</keyword>
</DOC>